LabCorp Extends Tender Offer for Orchid Cellmark Again | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of America today extended its cash tender offer for Orchid Cellmark to Aug. 12, 5 p.m. EDT.

The extension is the fourth as the US Federal Trade Commission seeks additional information about the deal. The $85.4 million deal was originally announced in April and was expected to close in the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.